Narayana Hrudayalaya Ltd. · NSE:NH
Narayana Hrudayalaya — Q4 FY25 Earnings Presentation
26 slides from Narayana Hrudayalaya's earnings presentation, May 23, 2025
Slide 1: Submission letter to stock exchanges
Date of submission: May 23, 2025 To, To, The Secretary The Secretary Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Mumbai – 400 051 Dalal Street, Mumbai – 400
Slide 2: Earnings Update Q4 FY25 and FY25
Earnings Update Q4 FY25 and FY25 August 02, 2023
Slide 3: Index
Topic Slide No. Our Footprint 03 Narayana Health at a Glance 04 Q4 FY25 and FY25 Highlights 05 Index Capex 20 Digital Transformation Initiatives 21 Narayana Health ESG Vision – “Health For All” 22 Shareholding Pattern 23 2
Slide 4: Our Footprint
Our Footprint South As on 1st April 2025 Hospitals - 6 | Heart Centres - 2 | Clinics - 12 | Diagnostic Centre - 1 Operational beds - 2,078 (Hospitals) - 132 (Heart Centres) Delhi NCR East Hospitals - 7 | Clinics - 4| Dialysis Centre - 1 Jaipur Operational beds - 2,025 Guwahati Ahmedabad Jamshedpur R
Slide 5: Narayana Health – At Glance
Narayana Health – At Glance 5,914 Facility Details No. of Facilities Operational Beds Capacity Beds Owned / Operated Hospitals(1,3) 18 5,282 6.6 Mns(2) Average Effective Capital Cost per Operational Bed Heart Centres 2 132 Clinics and Dialysis Centre 18 0 Total 18,828 Clinical : 11,554 Non-clinical
Slide 6: Key Highlights – Operational & Financial Performance (Q4 FY25 and FY25)
Key Highlights – Operational & Financial Performance (Q4 FY25 and FY25) • Narayana Health Group has successfully performed the following procedures: • 1200+ Robot-Assisted Surgical procedures in FY25 • 332 Robotic Cardiac Surgery in FY25 • 380+ Robotic Procedures in Q4FY25 • Narayana Institute of Ca
Slide 7: India Operations – Revenue (Q4 FY25)
INR Mns India Operations – Revenue (Q4 FY25) Total* Domestic 12,004 10,548 11,076 12,004 10,537 10,018 10,044 10,004 10,004 9,066 8,004 5.0% QoQ 8,004 4.9% QoQ 6,004 6,004 4,004 4,004 2,004 2,004 4 4 Q4 FY24 Q3 FY25 Q4 FY25 Q4 FY24 Q3 FY25 Q4 FY25 10.6% YoY 16.2% YoY International Integrated Care -
Slide 8: India Operations – Revenue (FY25)
INR Mns India Operations – Revenue (FY25) Total* Domestic 50,004 43,469 50,004 39,078 40,675 40,004 40,004 35,420 30,004 30,004 20,004 20,004 10,004 10,004 4 4 FY24 FY25 FY24 FY25 11.2% YoY 14.8% YoY International Integrated Care - NHIC and NHIL 4000 3,438 418 3500 3000 405 2,376 2500 305 2000 220 1
Slide 9: India Hospital Operations – Revenue Mix (Q4 FY25)
India Hospital Operations – Revenue Mix (Q4 FY25) Business Mix(7,8) Specialty-Profile(4,7,8) Payor-Profile(4,7,8) 4% 16% 19% 25% 34% 4% 8% 46% 2% 73% 9% 0% 13% 32% 16% Owned Hospitals (1) Cardiac Sciences Medicine and GI sciences Domestic Walk-in patients Operated Hospitals (2) Oncology Renal Scienc
Slide 10: India Hospital Operations – Revenue Mix (FY25)
India Hospital Operations – Revenue Mix (FY25) Business Mix(7,8) Specialty-Profile(4,7,8) Payor-Profile(4,7,8) 6% 16% 25% 33% 19% 4% 8% 45% 1% 73% 9% 0% 13% 30% 16% Owned Hospitals (1) Cardiac Sciences Medicine and GI sciences Domestic Walk-in patients Operated Hospitals (2) Oncology Renal Sciences
Slide 11: Operational Review – India Hospitals (Q4 FY25)
Operational Review – India Hospitals (Q4 FY25) Average Revenue Per Patient (IP & OP) (1,2) ALOS INR ‘000 Days 4.7 4.5 153.9 4.5 4.5 136.7 141.5 4.5 OP 4.3 IP 4.1 4.4 4.6 4.8 3.9 3.7 Q4 FY24 Q3 FY25 Q4 FY25 Q4 FY24 Q3 FY25 Q4 FY25 Patient Footfalls (IP & OP)(1,3) 94 ICU Occupied Bed Days 93 ‘000 599
Slide 12: Operational Review – India Hospitals (FY25)
Operational Review – India Hospitals (FY25) Average Revenue Per Patient (IP & OP) (1,2) ALOS INR ‘000 141.9 Days 129.5 4.7 4.5 4.5 4.5 OP 4.3 IP 4.1 4.3 4.6 3.9 3.7 FY24 FY25 FY24 FY25 Patient Footfalls (IP & OP)(1,3) 430 ICU Occupied Bed Days ‘000 2,411 2,443 ‘000 368 372 380 330 OP 280 230 IP 180
Slide 13: Cluster Split – India Hospitals (Q4 FY25)
Cluster Split – India Hospitals (Q4 FY25) This considers owned/operated hospitals & heart centers in India Southern Eastern Western Bangalore Kolkata Northern Peripheral Peripheral • NICS • Mysore • RTIICS • Jamshedpur • Mumbai • Gurugram Regions • MSMC • Shimoga • Barasat • Guwahati • Ahmedabad • N
Slide 14: Cluster Split – India Hospitals (FY25)
Cluster Split – India Hospitals (FY25) This considers owned/operated hospitals & heart centers in India Southern Eastern Western Bangalore Kolkata Northern Peripheral Peripheral • NICS • Mysore • RTIICS • Jamshedpur • Mumbai • Gurugram Regions • MSMC • Shimoga • Barasat • Guwahati • Ahmedabad • New
Slide 15: Profitability Snapshot – India Hospitals (Q4 FY25)
Profitability Snapshot – India Hospitals (Q4 FY25) Excludes Jammu, NHIC, NHIL, ATHMA & MEDHA (2) EBITDA and EBITDA Margin (1) Cost Structure INR ‘Mns % of Operating Revenues Q4 FY24 Q3 FY25 Q4 FY25 Chart Title Share Rental / Revenue (7) 2,500 21.5% 22.0% 3% 2% 2% 2,400 21.0% 100% 2,300 90% 12% 12% 1
Slide 16: Profitability Snapshot – India Hospitals (FY25)
Profitability Snapshot – India Hospitals (FY25) Excludes Jammu, NHIC, NHIL, ATHMA & MEDHA (2) EBITDA and EBITDA Margin (1) Cost Structure INR ‘Mns % of Operating Revenues FY24 FY25 Chart Title Share Rental / Revenue (7) 10,000 20.7% 21.0% 3% 2% 9,000 100% 19.9% 19.0% 90% 12% 12% 8,000 17.0% 80% (6)
Slide 17: NH Integrated Care: Snapshot
NH Integrated Care: Snapshot Program running since September 2022 at select Bengaluru locations 10* 128,655* ₹123.40 Mn.* ₹17.34 Mn.** Q4 FY25 Q4 FY25 FY25 As on 31st March 2025 Points of Presence Patient Transactions Revenue - Integrated Care GWP - Insurance Integrated Care now available at ten loc
Slide 18: Operational Review – Cayman Islands (Q4 FY25)
Operational Review – Cayman Islands (Q4 FY25) Average Revenue Per Patient (IP & OP) Operating Revenues US$ ‘00040.0 34.9 US$ Mns 32.0 49.0 29.1 44.1 30.0 OP 44.0 20.0 39.0 IP 35.1 34.0 30.4 10.0 1.1 1.3 1.4 29.0 0.0 24.0 Q4 FY24 Q3 FY25 Q4 FY25 Q4 FY24 Q3 FY25 Q4 FY25 Discharges Out-Patients 850 812
Slide 19: Operational Review – Cayman Islands (FY25)
Operational Review – Cayman Islands (FY25) Average Revenue Per Patient (IP & OP) Operating Revenues US$ ‘00040.0 US$ Mns 31.1 32.6 174.0 30.0 139.9 OP 123.9 124.0 IP 20.0 10.0 74.0 1.2 1.4 0.0 24.0 FY24 FY25 FY24 FY25 Discharges Out-Patients 40,504 2,950 42,500 38,851 2,449 2,550 37,500 2,450 32,500
Slide 20: Consolidated Financial Performance
Consolidated Financial Performance Figures in INR Mns, unless stated otherwise Profit and Loss Statement(1) Key Balance Sheet Items(1) Particulars (INR Mns) Q4 FY25 FY25 Particulars 31st Mar 2025 Total Operating Revenue 14,754 54,830 Shareholder Equity 36,282 Consumption 3,053 11,364 Doctors Expense
Slide 21: Expansion: Progress Status & Capex Strategy
Expansion: Progress Status & Capex Strategy Building to strengthen our presence in flagship regions Current Bed Capacity Bed Capacity Addition Bed Capacity Target Capex Head FY25 (P) FY25 (A) FY26 (P) 00 0 00 00 Greenfield/ 0 9,100 5,145 4,240 0 0 Inorganic Brownfield/ Capacity 1,350 159 159 Additio
Slide 22: Digital Transformation Initiatives
Digital Transformation Initiatives Impact | Mobile Apps Launch | New Products Initiatives | Business GTM | Athma Adoption of the nursing app has A new digital incident and document AI-led automation of supply chain Added 350 new beds across 3 improved the quality of management system has been tasks
Slide 23: NH ESG Vision – “Health For All”
Actual FY 24~25 (T – Target FY 24~25) NH ESG Vision – “Health For All” A Healthy Planet By being conscious about impact on the environment, prioritizing consumption efficiency and resource optimization 35% Carbon Neutral 100% Optimized 50% less Renewable Energy By 2040 Waste-water recycling by Waste
Slide 24: Shareholding Pattern
Shareholding Pattern As on 31st Mar 2025(1) ESOP Trust DIIs 0.7% Total Number of Shares 10.0% 204,360,804 FIIs 9.7% Key DIIs Key FIIs Nippon Life India Asset Management Vanguard Index Funds Axis Asset Management Franklin Templeton Investment Funds DSP Asset Management Simcah Partners LP Others Promo
Slide 25: Disclaimer and Contact Details
Disclaimer and Contact Details No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as
Slide 26: Take Care
i. C Take Care